Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on May 5, 2025
Best Premature Ejaculation Pills: Treatment, Meaning, How to Treat, What is Premature Ejaculation, Early Ejaculation Problem, How To Avoid Quick Discharge Of Sperm, Causes (Performer 8)
GlobeNewswire
·
May 5, 2025
Glasgow, May 05, 2025 (GLOBE NEWSWIRE) -- 2025: Introduction Performer 8 is a reliable dietary supplement designed to enhance testosterone levels and improve male sexual health. Many men have reported positive outcomes after using it. If you're over 18 and …
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
GlobeNewswire
·
May 5, 2025
APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life science incubator MBC BioLabs for a brand new facility located …
Aclarion Welcomes Advocate Health as CLARITY Trial Site
GlobeNewswire
·
May 5, 2025
Advocate Health actively participates in research studies and is an innovator in technology, including spine The CLARITY trial is designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the …
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 5, 2025
Pipeline: Delivered on our commitment to a more focused R…
Best Protein Powders For Muscle Gain: New Report Reveals Which Protein Powders Actually Work.
GlobeNewswire
·
May 5, 2025
New York, May 05, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted platform for expert product research and testing, has released its highly anticipated guide to the best protein powders for building muscle. The newly published report is designed to help …
Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
GlobeNewswire
·
May 5, 2025
Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified conditions. Daix (France), New York City (New York, United States), May 5, 2025 – Inventiva (Euronext Paris and Nasdaq: …
Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros
GlobeNewswire
·
May 5, 2025
Le financement intervient à la suite de la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et à la suite de l’atteinte d’autres conditions préalables. Daix (France), New York City (New York …
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
GlobeNewswire
·
May 5, 2025
Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall Survival of 23 months from date of diagnosis [95% CI; 17 …
Smith+Nephew stellt sein CORI™ Surgical System in chirurgischen Kliniken in Deutschland, Österreich und der Schweiz vor
GlobeNewswire
·
May 5, 2025
Die Roadshow „CORI on Tour“ zeigt die neuesten Fortschritte in der robotergestützten Chirurgie für Knie- und Hüftgelenkersatz Smith+Nephew (LSE:SN, NYSE:SNN), das globale Medizintechnikunternehmen, kündigt heute eine monatelange Roadshow durch …
Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland
GlobeNewswire
·
May 5, 2025
“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a months-long roadshow across central Europe to …
NANOBIOTIX PRÉSENTE LES RÉSULTATS COMPLETS DE L’ÉTUDE DE PHASE 1 ÉVALUANT JNJ-1900 (NBTXR3) DANS LE CANCER DU PANCREAS
GlobeNewswire
·
May 5, 2025
Les résultats ont démontré un bon profil de tolérance, une faisabilité d’injection satisfaisante, ainsi que des signaux cliniques encourageants en matière d‘activité antitumorale chez des patients atteints d’un cancer du pancréas localement avancé ou à la …
Dr. Jacob Buinewicz Achieves Double Board Certification
GlobeNewswire
·
May 5, 2025
DOYLESTOWN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Just in time for Mental Health Awareness Month in May, Dr. Jacob Buinewicz is proud to announce that he has achieved a second board certification from the American Board of Psychiatry and Neurology. Dr. …
GENFIT to Present Latest ACLF Research at EASL Congress 2025
GlobeNewswire
·
May 5, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
GlobeNewswire
·
May 5, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 5 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions
GlobeNewswire
·
May 5, 2025
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, 2025 – Roquette, a global leader in plant-based …
Roquette présente une nouvelle organisation à la suite de l’acquisition d’IFF Pharma Solutions
GlobeNewswire
·
May 5, 2025
Roquette présente une nouvelle organisation à la suite de l’acquisition d’IFF Pharma Solutions L’entreprise se structure avec deux Business Groups repensés et renforcés, et nomme leurs nouveaux dirigeants Lille, le 5 mai 2025 – Roquette, un leader mondial …
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
GlobeNewswire
·
May 5, 2025
ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today a co-discovery alliance …
Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
GlobeNewswire
·
May 5, 2025
Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the …